Cargando…
Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Microbiology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872632/ https://www.ncbi.nlm.nih.gov/pubmed/36533934 http://dx.doi.org/10.1128/aac.02201-21 |
| _version_ | 1784877444701880320 |
|---|---|
| author | Trang, M. Hammel, J. P. Lakota, E. A. Safir, M. C. Bhavnani, S. M. Friedrich, L. Steenbergen, J. N. McGovern, P. C. Tzanis, E. Rubino, C. M. |
| author_facet | Trang, M. Hammel, J. P. Lakota, E. A. Safir, M. C. Bhavnani, S. M. Friedrich, L. Steenbergen, J. N. McGovern, P. C. Tzanis, E. Rubino, C. M. |
| author_sort | Trang, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9872632 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society for Microbiology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98726322023-01-25 Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia Trang, M. Hammel, J. P. Lakota, E. A. Safir, M. C. Bhavnani, S. M. Friedrich, L. Steenbergen, J. N. McGovern, P. C. Tzanis, E. Rubino, C. M. Antimicrob Agents Chemother Letter to the Editor American Society for Microbiology 2022-12-19 /pmc/articles/PMC9872632/ /pubmed/36533934 http://dx.doi.org/10.1128/aac.02201-21 Text en Copyright © 2022 Trang et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editor Trang, M. Hammel, J. P. Lakota, E. A. Safir, M. C. Bhavnani, S. M. Friedrich, L. Steenbergen, J. N. McGovern, P. C. Tzanis, E. Rubino, C. M. Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia |
| title | Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia |
| title_full | Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia |
| title_fullStr | Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia |
| title_full_unstemmed | Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia |
| title_short | Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia |
| title_sort | omadacycline pharmacokinetics: influence of mortality risk score among patients with community-acquired bacterial pneumonia |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872632/ https://www.ncbi.nlm.nih.gov/pubmed/36533934 http://dx.doi.org/10.1128/aac.02201-21 |
| work_keys_str_mv | AT trangm omadacyclinepharmacokineticsinfluenceofmortalityriskscoreamongpatientswithcommunityacquiredbacterialpneumonia AT hammeljp omadacyclinepharmacokineticsinfluenceofmortalityriskscoreamongpatientswithcommunityacquiredbacterialpneumonia AT lakotaea omadacyclinepharmacokineticsinfluenceofmortalityriskscoreamongpatientswithcommunityacquiredbacterialpneumonia AT safirmc omadacyclinepharmacokineticsinfluenceofmortalityriskscoreamongpatientswithcommunityacquiredbacterialpneumonia AT bhavnanism omadacyclinepharmacokineticsinfluenceofmortalityriskscoreamongpatientswithcommunityacquiredbacterialpneumonia AT friedrichl omadacyclinepharmacokineticsinfluenceofmortalityriskscoreamongpatientswithcommunityacquiredbacterialpneumonia AT steenbergenjn omadacyclinepharmacokineticsinfluenceofmortalityriskscoreamongpatientswithcommunityacquiredbacterialpneumonia AT mcgovernpc omadacyclinepharmacokineticsinfluenceofmortalityriskscoreamongpatientswithcommunityacquiredbacterialpneumonia AT tzanise omadacyclinepharmacokineticsinfluenceofmortalityriskscoreamongpatientswithcommunityacquiredbacterialpneumonia AT rubinocm omadacyclinepharmacokineticsinfluenceofmortalityriskscoreamongpatientswithcommunityacquiredbacterialpneumonia |